Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Virology

• Publication date

  2000-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/VIRO.2000.0633PMID 11118363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1

  2000cited by this paper
• Simian Immunodeficiency Viruses of Diverse Origin Can Use CXCR4 as a Coreceptor for Entry into Human Cells

  2000cited by this paper
• Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization

  1999cited by this paper
• Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

  1999cited by this paper
• Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo.

  1999cited by this paper
• Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA.

  1999cited by this paper
• Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge.

  1999cited by this paper
• Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function*

  1999cited by this paper
• Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques

  1999cited by this paper
• Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex.

  1999cited by this paper
• Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

  1998cited by this paper
• The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokineand HIV-1-blocking human antibodies.

  1998cited by this paper
• First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

  1998cited by this paper
• Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

  1998cited by this paper
• Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen

  1998cited by this paper
• Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts.

  1998cited by this paper
• Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.

  1998cited by this paper
• Interaction of Chemokine Receptor CCR5 with its Ligands: Multiple Domains for HIV-1 gp120 Binding and a Single Domain for Chemokine Binding

  1997cited by this paper
• CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro

  1997cited by this paper
• Two Orphan Seven-Transmembrane Segment Receptors Which Are Expressed in CD4-positive Cells Support Simian Immunodeficiency Virus Infection

  1997cited by this paper
• Expression cloning of new receptors used by simian and human immunodeficiency viruses

  1997cited by this paper
• DNA increases the potency of vaccination against infectious diseases.

  1997cited by this paper
• DNA vaccines.

  1997cited by this paper
• Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes

  1997cited by this paper
• Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

  1997cited by this paper
• The influence of MT‐2 tropism on the prognostic implications of the Δ32 deletion in the CCR‐5 gene

  1997cited by this paper
• DNA-based immunization induces anti-CD4 antibodies directed primarily to native epitopes.

  1997cited by this paper
• Amplification of T‐Cell and Antibody Responses in DNA‐Based Immunization with HIV‐1 Nef by Co‐Injection with a GM‐CSF Expression Vector

  1997cited by this paper
• Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.

  1996cited by this paper
• Protection against Mucosal SIVsm Challenge in Macaques Infected with a Chimeric SIV that Expresses HIV Type 1 Envelope

  1996cited by this paper
• Identification of a major co-receptor for primary isolates of HIV-1

  1996cited by this paper
• The role of a mutant CCR5 allele in HIV–1 transmission and disease progression

  1996cited by this paper
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

  1995cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.

  1994cited by this paper
• "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.

  1992cited by this paper
• Immunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response.

  1991cited by this paper
• Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins.

  1991cited by this paper
• A capture enzyme immunoassay for detection of HIV-2/SIV antigen.

  1991cited by this paper
• Epitope mapping of the HIV-1 gag region with monoclonal antibodies.

  1990cited by this paper
• Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

  1990cited by this paper
• Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells

  1989cited by this paper

• Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev

  2021cites this paper
• A Vaccine against CCR5 Protects a Subset of Macaques upon Intravaginal Challenge with Simian Immunodeficiency Virus SIVmac251

  2013cites this paper
• Induction of mucosal immunity using virus-like particle based vaccines

  2011cites this paper
• Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine.

  2009cites this paper
• CCR5 antagonism in HIV infection: ways, effects, and side effects

  2009cites this paper
• HIV-1 and the self-nonself connection: how to sleep with the enemy and be much better off.

  2008cites this paper
• Inhibition of HIV‐1 entry by antibodies: potential viral and cellular targets

  2007cites this paper
• Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity

  2007cites this paper
• Innate and Adaptive Mucosal Immunity in Protection against HIV Infection

  2006cites this paper
• DNA Vaccines: Recent Developments and Future Possibilities

  2006cites this paper
• Therapeutic immunization for HIV

  2006cites this paper
• Effects of Immunization with CCR5-Based Cycloimmunogen on Simian/HIVSF162P3 Challenge1

  2006cites this paper
• Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.

  2005cites this paper
• Innate immunity in experimental SIV infection and vaccination.

  2005cites this paper
• Challenge SF 162 P 3 Cycloimmunogen on Simian / HIV Effects of Immunization with CCR 5-Based

  2005cites this paper
• Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies

  2004cites this paper
• Humoral Mucosal and Systemic Immunity Results in Long-Term HIV-1 Neutralizing Prime-Boost Immunization Regimen in Mice Intranasal HIV-1-gp160-DNA/gp41 Peptide

  2004cites this paper
• Therapeutic vaccination against HIV

  2004cites this paper
• Selection of active ScFv to G-protein-coupled receptor CCR5 using surface antigen-mimicking peptides.

  2004cites this paper
• Induction of Autoantibodies to CCR5 in Macaques and Subsequent Effects upon Challenge with an R5-Tropic Simian/Human Immunodeficiency Virus

  2004cites this paper
• CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection.

  2004cites this paper
• Induction of Autoantibodies to CCR 5 in Macaques and Subsequent Effects upon Challenge with an R 5-Tropic Simian / Human Immunodeficiency Virus

  2004cites this paper
• Shape‐mimetics of G‐protein‐coupled receptors in therapeutic drug design and screening

  2004cites this paper
• From Microbiology and Tumor Biology Center (MTC), Karolinska Institutet and the Swedish Institute for Infectious Disease Control, Stockholm, Sweden.

  2004cites this paper
• Intranasal HIV-1-gp160-DNA/gp41 Peptide Prime-Boost Immunization Regimen in Mice Results in Long-Term HIV-1 Neutralizing Humoral Mucosal and Systemic Immunity1

  2004cites this paper
• Chapter 10 – Simian Retroviruses

  2004cites this paper
• Concepts in DNA immunization overcoming viral diversity and enhancing plasmid immunogenicity

  2004cites this paper
• A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection

  2003cites this paper
• Genetic Immunization Against HIV

  2003cites this paper
• Innate and adaptive mucosal immunity in protection against HIV infection.

  2003cites this paper
• Strategies of gene and immune therapy for tumors and viral diseases

  2003cites this paper
• HIV immunology better understood and vaccination attempts started.

  2002cites this paper
• The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection.

  2002cites this paper
• Preclinical AIDS vaccine research: survey of SIV, SHIV, and HIV challenge studies in vaccinated nonhuman primates

  2002cites this paper
• Mucosal immunity and vaccination against HIV

  2002cites this paper
• Allo‐immunization elicits CCR5 antibodies, SDF‐1 chemokines, and CD8‐suppressor factors that inhibit transmission of R5 and X4 HIV‐1 in women

  2002cites this paper
• HIV subtypes and recombination strains--strategies for induction of immune responses in man.

  2002cites this paper